| 1 |
Dibley L, Khoshaba B, Artom M, Van Loo V, Sweeney L, Syred J, Windgassen S, Moffatt G, Norton C; members of the IBD-BOOST PPI team. Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support. Dig Dis Sci 2021;66:3330-42. [PMID: 33164146 DOI: 10.1007/s10620-020-06698-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 2 |
Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis 2018;36:271-80. [PMID: 29763907 DOI: 10.1159/000489487] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 3 |
Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9. [PMID: 28846594 DOI: 10.3390/nu9090940] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 4 |
Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016;55:897-906. [DOI: 10.1007/s00394-015-0922-1] [Cited by in Crossref: 212] [Cited by in F6Publishing: 270] [Article Influence: 26.5] [Reference Citation Analysis]
|
| 5 |
Sobczak M, Cami-Kobeci G, Sałaga M, Husbands SM, Fichna J. Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms. Eur J Pharmacol 2014;736:63-9. [PMID: 24815321 DOI: 10.1016/j.ejphar.2014.04.038] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
